Shanghai, China

Honchung Tsui

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Honchung Tsui - Innovator in Pharmaceutical Compounds

Introduction

Honchung Tsui is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceutical compounds. He holds a total of 9 patents, showcasing his innovative approach to drug development.

Latest Patents

His latest patents include novel triazolo-pyrimidine compounds and pyrazine compounds, both targeting adenosine receptors, particularly A2a. The triazolo-pyrimidine compounds are designed for use in pharmaceutical compositions aimed at treating adenosine receptor-associated diseases, including various types of cancer such as non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), prostate cancer, and breast cancer. Similarly, the pyrazine compounds also focus on the same therapeutic targets and applications.

Career Highlights

Throughout his career, Honchung Tsui has worked with notable companies, including Dizal Pharmaceutical Co., Ltd. His work has been instrumental in advancing the understanding and treatment of diseases linked to adenosine receptors.

Collaborations

Honchung has collaborated with esteemed colleagues such as Zhenfan Yang and Xiaolin Zhang, contributing to a rich environment of innovation and research in the pharmaceutical industry.

Conclusion

With a strong portfolio of patents and a commitment to advancing medical science, Honchung Tsui continues to be

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…